Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Egevad

Showing results (21-30 of 379) with videos related to

Pageof 38
Sort By:
European Urology|April 16, 2022
Re: Valentin H. Meissner, Isabel Rauscher, Kristina Schwamborn, et al. Radical Prostatectomy Without Prior Biopsy Following Multiparametric Magnetic Resonance Imaging and Prostate-specific Membrane Antigen Positron Emission Tomography. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.11.019Hemamali Samaratunga, Brett Delahunt, Lars Egevad
Virchows Archiv : an International Journal of Pathology|August 5, 2025
Re: Bernhardt M, Hommerding O, Kreft T, Weinhold L, Schmid M, Kristiansen G, Prospective selective embedding of radical prostatectomy specimens is not inferior to full embedding regarding established and new prognostic parametersLars Egevad, Brett Delahunt, Hemamali Samaratunga
Pathology|September 28, 2017
The decline of medical publishing: the rise of the pseudo-journalBrett Delahunt, Hemamali Samaratunga, Lars Egevad
European Urology|February 22, 2021
Re: Svetlana Avulova, John C. Cheville, Christine M. Lohse, et al. Grading of Chromophobe Renal Cell Carcinoma: Evidence for a Four-tiered Classification Incorporating Coagulative Tumor Necrosis. Eur Urol 2021;79:225-31: Should Chromophobe Renal Cell Carcinoma Be Graded?Brett Delahunt, Hemamali Samaratunga, Lars Egevad
Pathology|May 1, 2018
Macroscopic features of prostate cancerClaes Lindh, Brett Delahunt, Lars Egevad
Pathology|August 8, 2025
Intraductal carcinoma of the prostate is a marker of invasive diseaseBrett Delahunt, Hemamali Samaratunga, Lars Egevad
Archives of Pathology & Laboratory Medicine|March 31, 2012
Implications of the International Society of Urological Pathology modified Gleason grading systemLars Egevad, Roberta Mazzucchelli, Rodolfo Montironi
International Journal of Urology : Official Journal of the Japanese Urological Association|February 19, 2017
Editorial Comment to Biopsy undergrading in men with Gleason score 6 and fatal prostate cancer in the European Randomized study of Screening for Prostate Cancer RotterdamLars Egevad, Hemamali Samaratunga, Brett Delahunt
Acta Oncologica (Stockholm, Sweden)|May 25, 2011
Pathology in prostate research: optimizing tissue qualityDaniel M Berney, Rodolfo Montironi, Lars Egevad
Pathology|November 30, 2020
Recent advances in urological pathologyLars Egevad, Hemamali Samaratunga, John N Eble
Pageof 38

Showing results (21-30 of 379) with videos related to

Sort By:
Pageof 38
European Urology|April 16, 2022
Re: Valentin H. Meissner, Isabel Rauscher, Kristina Schwamborn, et al. Radical Prostatectomy Without Prior Biopsy Following Multiparametric Magnetic Resonance Imaging and Prostate-specific Membrane Antigen Positron Emission Tomography. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.11.019Hemamali Samaratunga, Brett Delahunt, Lars Egevad
Virchows Archiv : an International Journal of Pathology|August 5, 2025
Re: Bernhardt M, Hommerding O, Kreft T, Weinhold L, Schmid M, Kristiansen G, Prospective selective embedding of radical prostatectomy specimens is not inferior to full embedding regarding established and new prognostic parametersLars Egevad, Brett Delahunt, Hemamali Samaratunga
Pathology|September 28, 2017
The decline of medical publishing: the rise of the pseudo-journalBrett Delahunt, Hemamali Samaratunga, Lars Egevad
European Urology|February 22, 2021
Re: Svetlana Avulova, John C. Cheville, Christine M. Lohse, et al. Grading of Chromophobe Renal Cell Carcinoma: Evidence for a Four-tiered Classification Incorporating Coagulative Tumor Necrosis. Eur Urol 2021;79:225-31: Should Chromophobe Renal Cell Carcinoma Be Graded?Brett Delahunt, Hemamali Samaratunga, Lars Egevad
Pathology|May 1, 2018
Macroscopic features of prostate cancerClaes Lindh, Brett Delahunt, Lars Egevad
Pathology|August 8, 2025
Intraductal carcinoma of the prostate is a marker of invasive diseaseBrett Delahunt, Hemamali Samaratunga, Lars Egevad
Archives of Pathology & Laboratory Medicine|March 31, 2012
Implications of the International Society of Urological Pathology modified Gleason grading systemLars Egevad, Roberta Mazzucchelli, Rodolfo Montironi
International Journal of Urology : Official Journal of the Japanese Urological Association|February 19, 2017
Editorial Comment to Biopsy undergrading in men with Gleason score 6 and fatal prostate cancer in the European Randomized study of Screening for Prostate Cancer RotterdamLars Egevad, Hemamali Samaratunga, Brett Delahunt
Acta Oncologica (Stockholm, Sweden)|May 25, 2011
Pathology in prostate research: optimizing tissue qualityDaniel M Berney, Rodolfo Montironi, Lars Egevad
Pathology|November 30, 2020
Recent advances in urological pathologyLars Egevad, Hemamali Samaratunga, John N Eble
Pageof 38